Tilray Medical joins Cannabis Europa London 2026 to shape future of medical cannabis policy in Europe

Tilray Medical, a global leader in medical cannabis, is participating in Cannabis Europa London 2026, a key forum for discussing medical cannabis regulation and patient access in Europe. The event gathers policymakers, healthcare professionals, and industry leaders to explore evidence-based approaches to cannabis policy, including clinical trials and public health data. Tilray's Director of International Medical Affairs, José Tempero, will join a panel on designing public policy through data and trials. Tilray also supports patient access through its UK-based Lyphe Clinic and continues to expand its global medical cannabis platform across more than 20 regulated markets.